Suppr超能文献

用于甲状腺乳头状癌患者分层和个性化管理的风险评分模型的开发与验证

Development and validation of a risk score model for patient stratification and personalized management of papillary thyroid cancer.

作者信息

Guo Honghao, Shen Na, Hu Yixuan, Hao Xingjie, Zhang Huiqiong, Huang Tao, Zhang Ning

机构信息

Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Gland Surg. 2024 Nov 30;13(11):2116-2127. doi: 10.21037/gs-24-344. Epub 2024 Nov 26.

Abstract

BACKGROUND

The status of central lymph node (CLN) is a crucial determinant for the initial treatment of papillary thyroid cancer (PTC), but preoperative ultrasound (US) has limited ability to accurately assess their condition. This study aimed to develop a risk score model for risk stratification of CLN metastasis in unifocal PTC patients to guide the initial treatment.

METHODS

A total of 5,374 patients diagnosed with unifocal PTC at Union Hospital between November 2009 and August 2022 were finally enrolled in the analysis, including 3,542 patients in derivation cohort and 1,832 patients in validation cohort. Stepwise multivariable logistic regression was used to build the risk score of CLN metastasis. Risk score weights were assigned by dividing the coefficients of the predictors with the lowest coefficient value in the final model and rounding to the nearest integer. Points were calculated for each patient by adding these weights.

RESULTS

Ten multivariable predictors constructed the final model, including age, gender, body mass index, Hashimoto's disease, tumor location, calcification, capsule abnormalities, CLN and lateral lymph node (LN) abnormalities and tumor size. Based on the scores derived from these variables, patients were classified into four risk categories: low [0-9], low to intermediate [10-13], intermediate to high [14-17] and high [≥18], corresponding to 20.34%, 37.42%, 59.65%, and 83.82% of the observed incidence of CLN metastasis in the derivation cohort, respectively. In derivation and validation cohorts, the area under the curve of the final model was 0.764 and 0.72, respectively.

CONCLUSIONS

Compared to relying solely on tumor size and LNs US findings, our risk score, incorporating demographic characteristics and routine pre-operative examinations, served as a more practical and effective tool for risk stratification of CLN metastasis in unifocal PTC patients, facilitating in clinical decision-making.

摘要

背景

中央淋巴结(CLN)状态是甲状腺乳头状癌(PTC)初始治疗的关键决定因素,但术前超声(US)准确评估其状况的能力有限。本研究旨在建立单灶性PTC患者CLN转移风险分层的风险评分模型,以指导初始治疗。

方法

最终纳入2009年11月至2022年8月在协和医院诊断为单灶性PTC的5374例患者进行分析,其中推导队列3542例,验证队列1832例。采用逐步多变量逻辑回归建立CLN转移风险评分。通过将最终模型中系数值最低的预测因子的系数相除并四舍五入到最接近的整数来分配风险评分权重。为每位患者计算这些权重的总和得到分数。

结果

最终模型由10个多变量预测因子构建而成,包括年龄、性别、体重指数、桥本氏病、肿瘤位置、钙化、包膜异常、CLN及侧方淋巴结(LN)异常和肿瘤大小。根据这些变量得出的分数,患者被分为四个风险类别:低风险[0 - 9分]、低至中风险[10 - 13分]、中至高风险[14 - 17分]和高风险[≥18分],分别对应推导队列中观察到的CLN转移发生率的20.34%、37.42%、59.65%和83.82%。在推导队列和验证队列中,最终模型的曲线下面积分别为0.764和0.72。

结论

与仅依靠肿瘤大小和LN的超声检查结果相比,我们纳入人口统计学特征和术前常规检查的风险评分,是单灶性PTC患者CLN转移风险分层更实用有效的工具,有助于临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b19d/11635556/b2e0704f4ef3/gs-13-11-2116-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验